IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-15
DOI
10.3389/fonc.2021.760971
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of SOCS proteins in the development of virus- induced hepatocellular carcinoma
- (2021) Jinyan Xie et al. Virology Journal
- New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology
- (2021) Maria D. Giraldez et al. Nature Reviews Gastroenterology & Hepatology
- Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3
- (2021) Weiya Cao et al. TOXICOLOGY MECHANISMS AND METHODS
- Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis
- (2021) Yu-Fu Zhou et al. Journal for ImmunoTherapy of Cancer
- Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway
- (2020) SHUICHI IWAHASI et al. ANTICANCER RESEARCH
- IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells
- (2020) Yunpeng Hao et al. VIRUS RESEARCH
- Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
- (2020) Yu-Chin Liu et al. Cells
- Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma
- (2020) Yifei Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway
- (2020) Tao Pan et al. ONCOLOGY REPORTS
- USP9X promotes the proliferation, invasion and metastasis of liver cancer cells through regulating the JAK2/STAT3 signaling
- (2020) Xingchao Song et al. Oncology Letters
- IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
- (2020) Wenjie Zhang et al. Journal for ImmunoTherapy of Cancer
- Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival
- (2020) Shu‐Kui Qin et al. CANCER SCIENCE
- DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling
- (2020) Zhi-Gao Hu et al. LIFE SCIENCES
- Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways
- (2020) Jing Chen et al. Molecular Medicine Reports
- IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
- (2020) Yu Li et al. OncoTargets and Therapy
- AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway
- (2020) Tianke Chen et al. Cell Death & Disease
- First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors
- (2020) Richard D. Baird et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 and p53: Dual Target for Cancer Therapy
- (2020) Thu-Huyen Pham et al. Biomedicines
- Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells
- (2019) James Ahodantin et al. CARCINOGENESIS
- Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib
- (2019) Jing Yang et al. PATHOLOGY RESEARCH AND PRACTICE
- Reciprocal regulation of miR‐206 and IL‐6/STAT3 pathway mediates IL6‐induced gefitinib resistance in EGFR‐mutant lung cancer cells
- (2019) Yanhua Yang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
- (2019) Anquan Shang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
- (2019) Tan Boon Toh et al. JOURNAL OF HEPATOLOGY
- The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma
- (2018) Xian Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- HBV Facilitated Hepatocellular Carcinoma Cells Proliferation by Up-Regulating Angiogenin Expression Through IL-6
- (2018) Xiaotang Zhou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling
- (2018) Paul Baran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells
- (2018) Jia Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma
- (2018) Zi Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Saffron carotenoids inhibit STAT3 activation and promote apoptotic progression in IL-6-stimulated liver cancer cells
- (2018) Buyun� Kim et al. ONCOLOGY REPORTS
- The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection
- (2018) Chia-Yen Dai et al. Oncotarget
- Tuning T cell receptor affinity to optimize clinical risk-benefit when targeting α-fetoprotein-positive liver cancer
- (2018) Roslin Y. Docta et al. HEPATOLOGY
- Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
- (2018) Shanshan Wang et al. Cell Death & Disease
- Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
- (2018) Guo-Juan Niu et al. Frontiers in Immunology
- Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage
- (2018) Niklas Prenissl et al. CYTOKINE
- Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model
- (2017) Reina Sasaki et al. HEPATOLOGY
- HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway
- (2017) Mingyue Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway
- (2017) Yasmeen M. Attia et al. Scientific Reports
- IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment
- (2016) Xin Zheng et al. CELLULAR SIGNALLING
- Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
- (2016) Morteza Ghandadi et al. CURRENT PHARMACEUTICAL DESIGN
- Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
- (2016) Xue Wang et al. JOURNAL OF HEPATOLOGY
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
- (2016) Brad H. Rovin et al. Arthritis & Rheumatology
- STAT3 is a key transcriptional regulator of cancer stem cell marker CD133 in HCC
- (2016) Sarani Ghoshal et al. HEPATOBILIARY SURGERY AND NUTRITION
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
- (2015) Waseem Ahmad Siddiqui et al. ARCHIVES OF TOXICOLOGY
- IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
- (2015) Jung-Ta Kao et al. BMC GASTROENTEROLOGY
- STAT3 the oncogene - still eluding therapy?
- (2015) Matthew S. Wake et al. FEBS Journal
- 4-Methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis
- (2015) Flavia Piccioni et al. GLYCOBIOLOGY
- Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
- (2015) Cheolhee Won et al. HEPATOLOGY
- Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma
- (2015) Takuji Okusaka et al. HEPATOLOGY RESEARCH
- Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition
- (2015) Jun Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The PI3K/AKT/mTOR interactive pathway
- (2015) Tulin Ersahin et al. Molecular BioSystems
- SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma
- (2015) L-C Fan et al. ONCOGENE
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Siltuximab (CNTO 328): a promising option for human malignancies
- (2015) Bao-An Chen et al. Drug Design Development and Therapy
- A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
- (2015) Hong Zhao et al. Oncotarget
- LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
- (2015) Mingxin Zuo et al. Oncotarget
- Epithelial to Mesenchymal Transition is Associated with Shorter Disease-Free Survival in Hepatocellular Carcinoma
- (2014) Suguru Yamada et al. ANNALS OF SURGICAL ONCOLOGY
- Blocking Bcl-2 Leads to Autophagy Activation and Cell Death of the HEPG2 Liver Cancer Cell Line
- (2014) Peng Du et al. Asian Pacific Journal of Cancer Prevention
- Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells11These authors contributed equally to this work.
- (2014) Meiyu Peng et al. CANCER LETTERS
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity
- (2014) Chia-Lin Chen et al. Hepatology International
- Modeling Tumor Microenvironments In Vitro
- (2014) Mingming Wu et al. JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
- The Biology and Medical Implications of Interleukin-6
- (2014) T. Tanaka et al. Cancer Immunology Research
- Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
- (2013) Aruljothi Subramaniam et al. BRITISH JOURNAL OF PHARMACOLOGY
- STAT3 mediates TGF-β1-induced TWIST1 expression and prostate cancer invasion
- (2013) Kyung Hwa Cho et al. CANCER LETTERS
- Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro
- (2013) George S. Wilson et al. CANCER LETTERS
- A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation
- (2013) X. Zhang et al. CANCER RESEARCH
- microRNA-mediated regulation of the tumor microenvironment
- (2013) Jonathan Chou et al. CELL CYCLE
- Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
- (2013) A. Quintas-Cardama et al. CLINICAL CANCER RESEARCH
- Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice
- (2013) Ivan Quétier et al. JOURNAL OF HEPATOLOGY
- Therapeutic modulators of STAT signalling for human diseases
- (2013) Gabriella Miklossy et al. NATURE REVIEWS DRUG DISCOVERY
- Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
- (2013) Mehmet Coskun et al. PHARMACOLOGICAL RESEARCH
- Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells
- (2013) Nagaraj Nagathihalli et al. OncoTargets and Therapy
- NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
- (2013) Yihui Fan et al. Protein & Cell
- p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation
- (2012) Ahmed Fahmi et al. CELLULAR SIGNALLING
- Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression
- (2012) Toshiki Oguro et al. EUROPEAN JOURNAL OF CANCER
- Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model
- (2012) H. Herranz et al. GENES & DEVELOPMENT
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
- (2012) Mercedes Rincon et al. International Journal of Biological Sciences
- Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor
- (2012) LIANG ZHOU et al. ONCOLOGY REPORTS
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
- (2012) Junfang Ji et al. SEMINARS IN ONCOLOGY
- Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin
- (2012) B. L. Slomiany et al. INFLAMMOPHARMACOLOGY
- The Significance of MMP-9 Over MMP-2 in HCC Invasiveness and Recurrence of Hepatocellular Carcinoma After Curative Resection
- (2011) Rongxin Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
- (2011) Stacey L Fossey et al. BMC CANCER
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis
- (2011) Emilie A. Bard-Chapeau et al. CANCER CELL
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma
- (2011) P Chu et al. SWISS MEDICAL WEEKLY
- Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling
- (2011) Kyle J. Thompson et al. HPB
- IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-Induced STAT3 phosphorylation in human hepatocellular cancer cells
- (2010) Yan Liu et al. CELL CYCLE
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- IL-6: from its discovery to clinical applications
- (2010) T. Kishimoto INTERNATIONAL IMMUNOLOGY
- Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor
- (2010) Ken Miyoshi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Activation of STAT3 Signal Pathway Correlates with Twist and E-Cadherin Expression in Hepatocellular Carcinoma and Their Clinical Significance
- (2010) Chuan-Hai Zhang et al. JOURNAL OF SURGICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started